Atika Capital Management LLC Purchases 1,500 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Atika Capital Management LLC increased its stake in Intuitive Surgical by 2.8%, owning 55,100 shares worth approximately $27.29 million, as it becomes the firm's 7th largest holding.
• Multiple hedge funds have also modified their holdings, with Brighton Jones LLC increasing its stake by 24.9% and Dark Forest Capital Management LP increasing theirs by 110.8% in the fourth quarter.
• Insider sales were noted with Gary S. Guthart selling 2,800 shares and EVP Myriam Curet selling 4,500 shares, resulting in significant decreases in their positions within the company.

Atika Capital Management LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 55,100 shares of the medical equipment provider's stock after purchasing an additional 1,500 shares during the quarter. Intuitive Surgical comprises 3.8% of Atika Capital Management LLC's holdings, making the stock its 7th biggest position. Atika Capital Management LLC's holdings in Intuitive Surgical were worth $27,289,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Tiemann Investment Advisors LLC grew its position in shares of Intuitive Surgical by 4.6% in the 1st quarter. Tiemann Investment Advisors LLC now owns 2,293 shares of the medical equipment provider's stock valued at $1,136,000 after purchasing an additional 101 shares during the period. Martingale Asset Management L P acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at approximately $2,041,000. Candriam S.C.A. grew its position in shares of Intuitive Surgical by 41.3% in the 1st quarter. Candriam S.C.A. now owns 349,931 shares of the medical equipment provider's stock valued at $173,311,000 after purchasing an additional 102,304 shares during the period. TFB Advisors LLC grew its position in shares of Intuitive Surgical by 2.5% in the 1st quarter. TFB Advisors LLC now owns 1,752 shares of the medical equipment provider's stock valued at $868,000 after purchasing an additional 42 shares during the period. Finally, GDS Wealth Management acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at approximately $227,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, insider Gary S. Guthart sold 2,800 shares of the stock in a transaction on Monday, July 28th. The stock was sold at an average price of $495.24, for a total value of $1,386,672.00. Following the sale, the insider owned 18,520 shares in the company, valued at approximately $9,171,844.80. This represents a 13.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,839 shares of company stock worth $7,896,972. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Up 1.3%

Shares of Intuitive Surgical stock traded up $6.28 on Friday, reaching $476.16. 2,023,902 shares of the company were exchanged, compared to its average volume of 1,973,062. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company has a market capitalization of $170.69 billion, a price-to-earnings ratio of 66.41, a PEG ratio of 4.99 and a beta of 1.59. The company has a 50-day moving average of $504.42 and a 200 day moving average of $521.58.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter in the prior year, the business posted $1.78 EPS. The business's revenue was up 21.4% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Wednesday. Citigroup restated a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Wells Fargo & Company boosted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research note on Wednesday, July 23rd. BTIG Research boosted their target price on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Finally, Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Thirteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.